Zanamivir for influenza in adults and children: Systematic review of clinical study reports and summary of regulatory comments

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Heneghan, Carl J ^a   Onakpoya, Igho ^a   Thompson, Matthew ^b   Spencer, Elizabeth A ^a   Jones, Mark ^c   Jefferson, Tom ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Cochrane Acute Respiratory Infections Group Via Puglie 23 ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIVIRAL AGENTS; CHILD; HUMANS; INFLUENZA, HUMAN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; ZANAMIVIR;

EID: 84898669638     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2547     Document Type: Article

References (21)

1. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009;339:b5106.
2. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev 2012;4:CD002744.
3. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2012;1:CD008965.
4. Requesting Relenza data. www.bmj.com/open-data/relenza.
5. TA168 Influenza-zanamivir, amantadine and oseltamivir (review): guidance. 2 2 www. nice.org.uk/nicemedia/live/11774/43268/43268.pdf
6. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children-a review of unpublished data. Cochrane Database Syst Rev 2011;1:CD008965 [subsequent amendments were published in 2012 and in the current review (see Feedback/Review Amendments 16 May 2013)].
7. Matheson NJ, Harnden AR, Perera R, Sheikh A, Symmonds-Abrahams M. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2007;1:CD002744.
8. Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2010;2:CD001265.
9. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions . Version 5.1.0, updated March 2011. Cochrane Collaboration, 2001. www.cochranehandbook. org.
10. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014:348:g2545.
11. Department of Health and Human services/FDA. Relenza (zanamivir for inhalation). www. fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM165384.pdf
12. Patrozou E, Mermel LA. Does influenza transmission occur from asymptomatic infection or prior to symptom onset? Public Health Rep 2009;124:193-6.
13. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
14. Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009;339:b3172.
15. Zanamivir (RELENZA): drug Information from WorstPills.org. www.worstpills.org/public/page.cfm?op-id=465
16. Department of Health and Human Services. Letter. www.fda.gov/downloads/ Drugs/DrugSafety/InformationbyDrugClass/UCM143854.pdf
17. Nguyen-Van-Tam JS. Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs. BMJ 1999;319:655-6.
18. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73.
19. Longini IM Jr, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004;159:623-33.
20. Cao B, Wang DY, Yu XM, Wei LQ, Pu ZH, Gao Y, et al. An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illness. Chin Med J (Engl) 2012;125:3002-7.
21. Williamson JC, Pegram PS. Respiratory distress associated with zanamivir. N Engl J Med 2000;342:661-2.